Development of a novel elisa-based point-of-care antigen test for sars-cov-2
AssigneeThe Regents of the University of California
InventorsYusaku Michael Shino, Airi Harui
Life of this patent
Estimating the term…
Abstract
Aspects of the present disclosure relate to methods and systems designed to utilize antibodies and viral inactivating/lysis agents to detect SARS-CoV-2 on a microfluidic channel-based platform, for example in samples obtained from nasal swabs taken from infected individuals. The rapid and accurate point of care COVID-19 diagnostic tests that are disclosed herein can transform medical professional's testing capabilities, and in this way improve the ability to control the COVID-19 pandemic.
Claims20
A method of detecting SARS-CoV-2 in a fluid sample comprising:
- combining the fluid sample with a capture antibody that binds to a SARS-CoV-2 peptide, wherein the capture antibody is coupled to a matrix;
- combining the fluid sample with a detection antibody that binds to a SARS-CoV-2 peptide, wherein the detection antibody is coupled to a detectable label;
- and
- observing the presence of SARS-CoV-2 bound by both the capture antibody and the detection antibody such that the presence of SARS-CoV-2 in the fluid sample is detected;
- wherein the capture antibody and the detection antibody are selected from the antibodies that bind to epitopes on SARS-CoV-2 bound by N6 antibody, N7 antibody, N11 antibody and/or N5 antibody.
A system for detecting the presence of SARS-CoV-2 in a fluid sample, the system comprising:
- a detection antibody that binds to a SARS-CoV-2 peptide, wherein the detection antibody is coupled to a detectable label;
- and
- a capture antibody that binds to a SARS-CoV-polypeptide, wherein the capture antibody is coupled to a matrix;
- wherein the capture antibody and the detection antibody are selected from the antibodies that bind to epitopes on the SARS-CoV-2 that are bound by N6 antibody, N7 antibody, N11 or N5 antibody.
A kit comprising at least two of:
- N6 antibody, N7 antibody, N11 antibody and N5 antibody.
Dependencies are inferred from the claim text.